Follow the Supriya Lifescience Limited share price and the full management transaction log of the company, a publicly traded company based in India. Shares are listed on IN IN, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Supriya Lifescience Limited has recorded 8 public disclosures. Market capitalisation: €78bn. The latest transaction was filed on 27 February 2024 (Purchase). Among the most active insiders: Satish Waman Wagh. Every trade is openly available.
8
Insider Decl.
0
Thresholds
€101,375
7 ops.
Buy Volume
·
1 ops.
Sell Volume
5Σ signal
Buys €101,375· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,819 of 26,211 companies
63.5
score / 100
Value
38
Quality
89
FCF yld0.5%
Earn yld3.0%
EV/EBITDA22.6x
ROE19%
Gross mgn69%
Net mgn25%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.